BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12634637)

  • 1. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States.
    Altekruse SF; Lacey JV; Brinton LA; Gravitt PE; Silverberg SG; Barnes WA; Greenberg MD; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Hildesheim A
    Am J Obstet Gynecol; 2003 Mar; 188(3):657-63. PubMed ID: 12634637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.
    Muñoz N; Franceschi S; Bosetti C; Moreno V; Herrero R; Smith JS; Shah KV; Meijer CJ; Bosch FX;
    Lancet; 2002 Mar; 359(9312):1093-101. PubMed ID: 11943256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of cervical cancer in the Philippines: a case-control study.
    Ngelangel C; Muñoz N; Bosch FX; Limson GM; Festin MR; Deacon J; Jacobs MV; Santamaria M; Meijer CJ; Walboomers JM
    J Natl Cancer Inst; 1998 Jan; 90(1):43-9. PubMed ID: 9428782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for cervical cancer in Thailand: a case-control study.
    Chichareon S; Herrero R; Muñoz N; Bosch FX; Jacobs MV; Deacon J; Santamaria M; Chongsuvivatwong V; Meijer CJ; Walboomers JM
    J Natl Cancer Inst; 1998 Jan; 90(1):50-7. PubMed ID: 9428783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV types and cofactors causing cervical cancer in Peru.
    Santos C; Muñoz N; Klug S; Almonte M; Guerrero I; Alvarez M; Velarde C; Galdos O; Castillo M; Walboomers J; Meijer C; Caceres E
    Br J Cancer; 2001 Sep; 85(7):966-71. PubMed ID: 11592767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
    Sasagawa T; Basha W; Yamazaki H; Inoue M
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States.
    Zelmanowicz Ade M; Schiffman M; Herrero R; Goldstein AM; Sherman ME; Burk RD; Gravitt P; Viscidi R; Schwartz P; Barnes W; Mortel R; Silverberg SG; Buckland J; Hildesheim A
    Int J Cancer; 2005 Sep; 116(4):599-605. PubMed ID: 15818615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix.
    Lacey JV; Swanson CA; Brinton LA; Altekruse SF; Barnes WA; Gravitt PE; Greenberg MD; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Kurman RJ; Hildesheim A
    Cancer; 2003 Aug; 98(4):814-21. PubMed ID: 12910527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum and red blood cell folate are moderately, but nonsignificantly associated with increased risk of invasive cervical cancer in U.S. women.
    Weinstein SJ; Ziegler RG; Frongillo EA; Colman N; Sauberlich HE; Brinton LA; Hamman RF; Levine RS; Mallin K; Stolley PD; Bisogni CA
    J Nutr; 2001 Jul; 131(7):2040-8. PubMed ID: 11435527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
    Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.
    Moreno V; Bosch FX; Muñoz N; Meijer CJ; Shah KV; Walboomers JM; Herrero R; Franceschi S;
    Lancet; 2002 Mar; 359(9312):1085-92. PubMed ID: 11943255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.
    Liaw KL; Glass AG; Manos MM; Greer CE; Scott DR; Sherman M; Burk RD; Kurman RJ; Wacholder S; Rush BB; Cadell DM; Lawler P; Tabor D; Schiffman M
    J Natl Cancer Inst; 1999 Jun; 91(11):954-60. PubMed ID: 10359548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adenocarcinoma of the uterine cervix--risk factors].
    Stefănescu BI
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):155-60. PubMed ID: 17595861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
    Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
    Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
    Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.
    Dillner J; Lehtinen M; Björge T; Luostarinen T; Youngman L; Jellum E; Koskela P; Gislefoss RE; Hallmans G; Paavonen J; Sapp M; Schiller JT; Hakulinen T; Thoresen S; Hakama M
    J Natl Cancer Inst; 1997 Sep; 89(17):1293-9. PubMed ID: 9293920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.
    Smith JS; Herrero R; Bosetti C; Muñoz N; Bosch FX; Eluf-Neto J; Castellsagué X; Meijer CJ; Van den Brule AJ; Franceschi S; Ashley R;
    J Natl Cancer Inst; 2002 Nov; 94(21):1604-13. PubMed ID: 12419786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.
    Madeleine MM; Anttila T; Schwartz SM; Saikku P; Leinonen M; Carter JJ; Wurscher M; Johnson LG; Galloway DA; Daling JR
    Int J Cancer; 2007 Feb; 120(3):650-5. PubMed ID: 17096345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.